Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome

BACKGROUND: Non-alcoholic fatty liver (NAFLD) and its related metabolic syndrome have become major threats to human health, but there is still a need for effective and safe drugs to treat these conditions. Here we aimed to identify potential drug candidates for NAFLD and the underlying molecular mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ruifeng, Yang, Jinjie, Wang, Xiaoming, Liu, Shuaiyang, Dong, Ruixiang, Wang, Zhenya, Yang, Zifeng, Zhang, Yingping, Cai, Zhiwei, Yang, Hailong, Hu, Yufeng, She, Zhi-Gang, Li, Hongliang, Zhou, Junjie, Zhang, Xiao-Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024454/
https://www.ncbi.nlm.nih.gov/pubmed/36932412
http://dx.doi.org/10.1186/s13020-023-00729-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024454/
https://www.ncbi.nlm.nih.gov/pubmed/36932412
http://dx.doi.org/10.1186/s13020-023-00729-5

Ejemplares similares